Tuesday, July 21, 2015 4:47:33 PM
This is not a pot stock.
This is phase 3 trials for a drug that might or might not get the wag.
This is orphan drug status for a raw plant CBD extract that GW owns outside of those trials.
protocols will be met.
If they can prove scientifically what all us yippies have been saying for the last 20 or so, it will be the breakthrough.
I'm just so glad that adults and children alike respond so well to Epidolex. I couldn't imagine what it's like to live with seizures.
This here is the medicine that all the scam stocks build upon. Beware, but always know,
GW is the real deal.
the other 99.9% are scams.
"The aim of the wise is not to secure pleasure, but to avoid pain."
-Aristotle
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM